Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrabenazine for Impulsivity in Huntington's Disease
NCT02509793Phase 4Unknown
- Start
- Aug 2018
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tetrabenazine in Huntington's disease (HD). Status: unknown.
02
Drugs
tetrabenazine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT02509793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509793.